-transparent.png){kind=logo}
We evaluated the usefulness of fusion vaccine prepared from IL-2-gene-transduced splenic dendritic cells (DCs) and fibrosarcoma tumor cells (QRsP) in treating of lung metastasis. The IL-2 or LacZ gene was transferred into spleen-derived DCs using an adenoviral vector. Irradiated QRsP tumor cells were fused with IL-2 gene transduced DCs (fusion/IL-2) or LacZ gene transduced DCs (fusion/LacZ) by polyethyleneglycol. These fusion cells expressed major histocompatibility complex (MHC) class I and MHC class II, CD86, CD11c and CD8alpha. IFN-gamma and cytotoxic T lymphocyte (CTL) activity of splenic lymphocytes in mice vaccinated with fusion cells increased significantly as compared with those of DC or tumor cells vaccinated mice. CTL levels in fusion/IL-2-vaccinated mice were higher than that in fusion/LacZ-vaccinated mice. The number of lung metastasis in the fusion/IL-2 or fusion/LacZ-vaccineatd mice was significantly lower than that in mice vaccinated with DCs, tumor or PBS. The introduction of the IL-2 gene into fusion cells produced more potent therapeutic effects. Our results suggest that the fusion cells prepared from IL-2 gene transduced spleen derived DCs and tumor cells have the ability to induce therapeutic effect against lung metastasis.
Fujio Ogawa, and
Hisae Iinuma, and
Kota Iwasaki, and
Junko Tamura, and
Harumi Kumagai, and
Tsuyoshi Inaba, and
Ryouji Fukushima, and
Okinaga Kota
October 2012,
Folia histochemica et cytobiologica,
Fujio Ogawa, and
Hisae Iinuma, and
Kota Iwasaki, and
Junko Tamura, and
Harumi Kumagai, and
Tsuyoshi Inaba, and
Ryouji Fukushima, and
Okinaga Kota
May 2000,
Cancer letters,
Fujio Ogawa, and
Hisae Iinuma, and
Kota Iwasaki, and
Junko Tamura, and
Harumi Kumagai, and
Tsuyoshi Inaba, and
Ryouji Fukushima, and
Okinaga Kota
June 2004,
Cancer biotherapy & radiopharmaceuticals,
Fujio Ogawa, and
Hisae Iinuma, and
Kota Iwasaki, and
Junko Tamura, and
Harumi Kumagai, and
Tsuyoshi Inaba, and
Ryouji Fukushima, and
Okinaga Kota
October 2011,
Immunobiology,
Fujio Ogawa, and
Hisae Iinuma, and
Kota Iwasaki, and
Junko Tamura, and
Harumi Kumagai, and
Tsuyoshi Inaba, and
Ryouji Fukushima, and
Okinaga Kota
December 1996,
Journal of immunology (Baltimore, Md. : 1950),
Fujio Ogawa, and
Hisae Iinuma, and
Kota Iwasaki, and
Junko Tamura, and
Harumi Kumagai, and
Tsuyoshi Inaba, and
Ryouji Fukushima, and
Okinaga Kota
March 2006,
Journal of immunology (Baltimore, Md. : 1950),
Fujio Ogawa, and
Hisae Iinuma, and
Kota Iwasaki, and
Junko Tamura, and
Harumi Kumagai, and
Tsuyoshi Inaba, and
Ryouji Fukushima, and
Okinaga Kota
May 1995,
Human gene therapy,
Fujio Ogawa, and
Hisae Iinuma, and
Kota Iwasaki, and
Junko Tamura, and
Harumi Kumagai, and
Tsuyoshi Inaba, and
Ryouji Fukushima, and
Okinaga Kota
June 2007,
Gene therapy,
Fujio Ogawa, and
Hisae Iinuma, and
Kota Iwasaki, and
Junko Tamura, and
Harumi Kumagai, and
Tsuyoshi Inaba, and
Ryouji Fukushima, and
Okinaga Kota
February 1999,
Gene therapy,
Fujio Ogawa, and
Hisae Iinuma, and
Kota Iwasaki, and
Junko Tamura, and
Harumi Kumagai, and
Tsuyoshi Inaba, and
Ryouji Fukushima, and
Okinaga Kota
February 2000,
Chinese medical journal,
